| Product NDC: | 43251-2281 | 
| Proprietary Name: | Natralia Eczema and Psoriasis | 
| Non Proprietary Name: | Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride | 
| Active Ingredient(s): | 6; 3; 20; 12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL & nbsp; Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | GEL | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43251-2281 | 
| Labeler Name: | LaCorium Health USA Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC | 
| Start Marketing Date: | 20090103 | 
| Package NDC: | 43251-2281-1 | 
| Package Description: | 200 mL in 1 BOTTLE (43251-2281-1) | 
| NDC Code | 43251-2281-1 | 
| Proprietary Name | Natralia Eczema and Psoriasis | 
| Package Description | 200 mL in 1 BOTTLE (43251-2281-1) | 
| Product NDC | 43251-2281 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride | 
| Dosage Form Name | GEL | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20090103 | 
| Marketing Category Name | UNAPPROVED HOMEOPATHIC | 
| Labeler Name | LaCorium Health USA Inc. | 
| Substance Name | GRAPHITE; POTASSIUM SULFATE; SODIUM BORATE; SODIUM CHLORIDE | 
| Strength Number | 6; 3; 20; 12 | 
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL | 
| Pharmaceutical Classes |